Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians

Detalles Bibliográficos
Autores principales: Banerjee, Rahul, Wang, Bo, Anderson, Larry D., McCaughan, Georgia, Mehra, Nikita, Cowan, Andrew J., Rajkumar, S. Vincent, Kaur, Gurbakhash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625982/
https://www.ncbi.nlm.nih.gov/pubmed/37926718
http://dx.doi.org/10.1038/s41408-023-00937-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625982/
https://www.ncbi.nlm.nih.gov/pubmed/37926718
http://dx.doi.org/10.1038/s41408-023-00937-0

Ejemplares similares